OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7475$2436.0057

Albis Co Ltd

Food Retail & DistributionVerified

Albis Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is assessed as low, with a current ratio of 1.02, suggesting limited short-term liquidity cushion. The price-to-book ratio of 0.64 indicates that the company's market value is below its book value, potentially signaling undervaluation or asset-heavy operations. Profitability metrics for Albis are modest, with a return on equity (ROE) of 1.3% and a return on assets (ROA) of 0.85%. These figures fall below the typical performance benchmarks for the Food Retail & Distribution industry, which often prioritize stable margins over high returns. The company's gross profit margin is 30.9%, calculated from a gross profit of ¥7.434 billion on total revenue of ¥24.068 billion, but this is not explicitly compared to industry medians due to the absence of industry_config data. Geographically and segment-wise, Albis' revenue concentration is not disclosed in the available data, but the company operates primarily in Japan, as indicated by the JPY financials and the ticker listing on the Tokyo Stock Exchange. The absence of segment-specific revenue breakdowns limits the ability to assess diversification or growth drivers within the business. Looking ahead, Albis is projected to see a modest growth trajectory, with no significant revenue deltas disclosed in the outlook. The company's current FY revenue is ¥24.068 billion, and while no specific next FY forecast is provided, the absence of dilution or liquidity flags suggests a stable operating environment. The company's price-to-earnings ratio of 49.52 is elevated, indicating that investors are paying a premium for earnings, which may reflect expectations of future growth or a low-risk profile. Risk factors for Albis include low liquidity and the potential for regulatory changes in the retail and distribution sector. The company's low dilution risk is supported by the absence of immediate filing-based flags, and the diluted shares outstanding are equal to the basic shares, indicating no near-term dilution pressure. The company's long-term debt of ¥3.576 billion is relatively low compared to total equity of ¥31.583 billion, further supporting a conservative capital structure. Recent events for Albis include the latest actual EPS of ¥157.62 and revenue of ¥100.951 billion, as reported by analysts. These figures suggest a strong performance in the most recent reporting period, though the discrepancy between the ¥100.951 billion revenue and the ¥24.068 billion in the financial snapshot may reflect different reporting periods or data sources.

30-day price · 7475-130.00 (-5.0%)
Low$2455.00High$2666.00Close$2485.00As of13 May, 00:00 UTC
Profile
CompanyAlbis Co Ltd
Ticker7475.T
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Albis Co Ltd operates in the Food & Drug Retailing sector, providing retail and distribution services for food and drug products.

Classification. Albis is classified under the Food Retail & Distribution industry within the Consumer Non-Cyclicals economic sector, with a confidence level of 0.92.

Albis Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is assessed as low, with a current ratio of 1.02, suggesting limited short-term liquidity cushion. The price-to-book ratio of 0.64 indicates that the company's market value is below its book value, potentially signaling undervaluation or asset-heavy operations. Profitability metrics for Albis are modest, with a return on equity (ROE) of 1.3% and a return on assets (ROA) of 0.85%. These figures fall below the typical performance benchmarks for the Food Retail & Distribution industry, which often prioritize stable margins over high returns. The company's gross profit margin is 30.9%, calculated from a gross profit of ¥7.434 billion on total revenue of ¥24.068 billion, but this is not explicitly compared to industry medians due to the absence of industry_config data. Geographically and segment-wise, Albis' revenue concentration is not disclosed in the available data, but the company operates primarily in Japan, as indicated by the JPY financials and the ticker listing on the Tokyo Stock Exchange. The absence of segment-specific revenue breakdowns limits the ability to assess diversification or growth drivers within the business. Looking ahead, Albis is projected to see a modest growth trajectory, with no significant revenue deltas disclosed in the outlook. The company's current FY revenue is ¥24.068 billion, and while no specific next FY forecast is provided, the absence of dilution or liquidity flags suggests a stable operating environment. The company's price-to-earnings ratio of 49.52 is elevated, indicating that investors are paying a premium for earnings, which may reflect expectations of future growth or a low-risk profile. Risk factors for Albis include low liquidity and the potential for regulatory changes in the retail and distribution sector. The company's low dilution risk is supported by the absence of immediate filing-based flags, and the diluted shares outstanding are equal to the basic shares, indicating no near-term dilution pressure. The company's long-term debt of ¥3.576 billion is relatively low compared to total equity of ¥31.583 billion, further supporting a conservative capital structure. Recent events for Albis include the latest actual EPS of ¥157.62 and revenue of ¥100.951 billion, as reported by analysts. These figures suggest a strong performance in the most recent reporting period, though the discrepancy between the ¥100.951 billion revenue and the ¥24.068 billion in the financial snapshot may reflect different reporting periods or data sources.
Key takeaways
  • Albis maintains a conservative capital structure with a low debt-to-equity ratio of 0.11.
  • The company's ROE of 1.3% and ROA of 0.85% indicate modest profitability.
  • The price-to-book ratio of 0.64 suggests the company is trading below its book value.
  • No immediate liquidity or dilution risks are flagged, supporting a stable operating environment.
  • The company's market price of ¥2,436 and P/E ratio of 49.52 indicate a premium valuation.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$24.07B
Gross profit$7.43B
Operating income$477.0M
Net income$411.0M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$48.60B
Total liabilities$17.02B
Total equity$31.58B
Cash & equivalents$5.37B
Long-term debt$3.58B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$92.07B$2.45B$2.11B$1.76B
FY-3$94.59B$1.91B$1.68B$1.37B
FY-2$97.80B$1.66B$1.55B$754.0M
FY-1$98.19B$1.84B$1.62B-$319.0M
FY0$100.95B$1.79B$1.32B-$2.71B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$48.46B$29.45B$6.93B
FY-3$48.00B$30.57B$6.14B
FY-2$49.64B$31.45B$5.69B
FY-1$52.89B$32.32B$6.22B
FY0$58.55B$32.98B$8.52B
PeriodOCFCapExFCFSBC
FY-4$4.22B-$1.86B$1.76B
FY-3$4.03B-$1.83B$1.37B
FY-2$4.47B-$2.30B$754.0M
FY-1$3.06B-$3.63B-$319.0M
FY0$5.00B-$6.08B-$2.71B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$24.07B$477.0M$411.0M
FQ-6$24.30B$317.0M$272.0M
FQ-5$25.70B$803.0M$631.0M
FQ-4$24.12B$245.0M$309.0M
FQ-3$25.00B$262.0M$256.0M
FQ-2$25.23B$350.0M$321.0M
FQ-1$26.32B$769.0M$468.0M
FQ0$24.41B$405.0M$280.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$48.60B$31.58B$5.37B
FQ-6$49.08B$31.77B$4.95B
FQ-5$51.35B$32.14B$4.30B
FQ-4$52.89B$32.32B$6.22B
FQ-3$56.19B$31.98B$8.91B
FQ-2$55.36B$32.15B$7.29B
FQ-1$57.80B$32.49B$5.59B
FQ0$58.55B$32.98B$8.52B
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$459.0M-$1.46B
FQ-5
FQ-4$3.06B-$3.63B
FQ-3
FQ-2$1.70B-$3.04B
FQ-1
FQ0$5.00B-$6.08B
Valuation
Market price$2436.00
Market cap$20.35B
Enterprise value$18.56B
P/E49.5
Reported non-GAAP P/E
EV/Revenue0.8
EV/Op income38.9
EV/OCF
P/B0.6
P/Tangible book0.6
Tangible book$31.58B
Net cash$1.80B
Current ratio1.0
Debt/Equity0.1
ROA0.9%
ROE1.3%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
Metric7475Activity
Op margin2.0%3.1% medp25 1.2% · p75 6.8%below median
Net margin1.7%2.0% medp25 0.7% · p75 4.1%below median
Gross margin30.9%26.1% medp25 17.2% · p75 32.0%above median
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity11.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Observations
IR observations
Last actual EPS157.62 JPY
Last actual revenue100,951,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:39 UTC#5341e55c
Market quoteclose JPY 2493.00 · shares 0.01B diluted
no public URL
2026-05-13 00:39 UTC#9747ea60
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 03:02 UTCJob: 53898b1b